We’ve all heard examples of poor priorities in the healthcare industry leading to increased risks. Here’s one more. Global stockpiles of snakebite antivenom are diminishing, in large part because it’s not a profitable medicine. According to Médecins Sans Frontières, allowing the supplies to run low will endanger or possibly even cost the lives of tens of thousands of people in Sub-Saharan Africa. If nothing is done, the supplies could run out within the next year.
Read the rest of Global snakebite antivenom supplies running out, tens of thousands of lives in danger
via Green Living - Building, Home, Auto & Lifestyles copy http://ift.tt/1KZ72Og
No comments:
Post a Comment